Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Revista Colombiana de Ciencias Químico - Farmacéuticas
Print version ISSN 0034-7418On-line version ISSN 1909-6356
Abstract
SANABRIA ROJAS, Andrea; MARTINEZ, José Ignacio and DIAZ ROJAS, Jorge Augusto. Colon cancer: Analysis of disease cost to III and IV stages in Cansercoop IPS. Rev. colomb. cienc. quim. farm. [online]. 2009, vol.38, n.2, pp.193-214. ISSN 0034-7418.
The cancer colon has an increased incidence in Colombia and is a leading causes of mortality and morbidity in this group of diseases with a high economic and emotional burden, from the standpoint of economic impact there is little information in the Colombian context, for this reason, this work makes a case study in a health institution providing services, applying the methodology of "Cost of Illness" based on the prevalence of disease. Aim: To estimate the whole costs, both direct and indirect to cancer colon; establishing a distribution resources to III and IV stages. Method: analysis cost of Illness was used in patients were diagnosed as having both III and IV stages with cancer colon, from January 2005 to October 2007; checking a base data in Cansercoop IPS. Results: 79 people were identified, 44 (III stage) and 35 (IV stage), 59.9% of all of them are women up to 60 years old and 58.2% belong to Salud Total. The total cost was $ 348.254.762, 98.4% were direct costs and 1.59% were indirect costs. Average cost for each patient was $ 1.700.816 (49.288-11.529.013), III stage and $ 7.653.742 (13.523-70.354.423), IV stage. 65.66% are medicines. Conclusions: the total costs, both III and IV stages were $ 77.143.347 and $ 271.111.415 in III stage and $182.570.717 in IV stage. This analysis can be considered as a preliminary study; however it means a step to subsequent economic health assessments.
Keywords : colon cancer; analysis "cost of illness"; directs costs; indirect costs; total costs.